News | April 28, 2023
Yasmin and Mirena to take back seat from Bayer’s future drug strategy, says GlobalData
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
Women of all ages will get round-the-clock access to comprehensive treatment
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
The array available for a subscription includes popular products to make menstrual hygiene a regular practice and extend further affordability to its users
It is the first-ever approval in India for the treatment of Female Pattern Hair Loss (FPHL) and will be available only on prescription by a dermatologist
The group now has 320 approvals and has so far filed over 400 ANDAs
Promising drug pipeline, focus on gene therapy and innovative digital health solutions will remain the key pillars of Bayer’s pharmaceutical business
Subscribe To Our Newsletter & Stay Updated
